Lichen China Limited Class A Ordinary Shares (LICN)
Lichen China Limited Class A Ordinary Shares (LICN) is a company involved in the distribution, marketing, and sale of personal care, household products, and other consumer goods in China. The company focuses on leveraging its extensive distribution network and marketing expertise to reach a broad customer base across various channels in China’s rapidly growing consumer market.
Company News
Univest Securities, LLC announced the closing of a $3.4 million registered direct offering for its client Lichen China Limited, a financial and taxation service provider. The offering involved the sale of 42.5 million shares of Lichen China's Class A ordinary shares.
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day s...
Normally, IPO activity gains momentum in the second quarter and peaks in June. This year was no exception.
Nextracker's initial public offering raises $638 million, as the IPO market shows signs of life after a strong start to the stock market in 2023.